Clinical Trial Update: Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating effectiveness and safety of tofacitinib in patients with extensive and recalcitrant alopecia areata has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Institute of Dermatology, Thailand | Conditions: Alopecia Areata | Phase 4 | Status: COMPLETED | Results posted: 2022-03-10